SmofKabiven peripher 1448 ml, Infusionsemulsion
7680624480049
CH-62448
B05BA10
07.01.2.
1 / 3
google
Details
- Product number
- 6244802
- CPT
- -
- Packaging group
- 4 x 1448
- Unit
- ml
- Composition
- I) Glucoselösung: glucosum 102 g ut glucosum monohydricum, aqua ad iniectabile q.s. ad solutionem pro 788 ml. II) Aminosäurelösung mit Elektrolyten: alaninum 6.4 g, argininum 5.5 g, glycinum 5.0 g, histidinum 1.4 g, isoleucinum 2.3 g, leucinum 3.4 g, lysinum anhydricum 3.0 g ut lysini acetas, methioninum 2 g, phenylalaninum 2.3 g, prolinum 5.1 g, serinum 3 g, taurinum 460 mg, threoninum 2 g, tryptophanum 910 mg, tyrosinum 180 mg, valinum 2.8 g, calcii chloridum anhydricum 260 mg ut calcii chloridum dihydricum, natrii glycerophosphas 1.9 g, magnesii sulfas anhydricus 550 mg ut magnesii sulfas heptahydricus, kalii chloridum 2 g, natrii acetas 1.6 g ut natrii acetas trihydricus, zinci sulfas anhydricus 6 mg ut zinci sulfas heptahydricus, aqua ad iniectabile q.s. ad solutionem pro 456 ml. III) Fettemulsion: sojae oleum raffinatum 12.2 g, triglycerida media 12.2 g, olivae oleum raffinatum 10.2 g, piscis oleum 6.1 g, int-rac-alpha-tocopherolum 33.3-45.9 mg, phospholipida ex ovo purificata, glycerolum, natrii oleas, aqua ad iniectabile q.s. ad emulsionem pro 204 ml. . I) et II) et III) corresp.: carbohydrata 71 g/l, aminoacida 32 g/l, nitrogenia 5.1 g/l, materia crassa 28 g/l, natrium 25 mmol/l, kalium 19 mmol/l, magnesium 3.2 mmol/l, calcium 1.6 mmol/l, phosphas 8.2 mmol/l, zincum 0.02 mmol/l, sulfas 3.2 mmol/l, chloridum 22 mmol/l, acetas 66 mmol/l, in emulsione recenter mixta. Corresp. 2900 kJ/l.
Articles (1)
SmofKabiven peripher 1448 ml, Infusionsemulsion
Infusionsemulsion
4 x 1448
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
II
|
6.4 G | Substance | Wirkstoff (Principe actif) |
|
I
|
102.0 G | Substance | Wirkstoff (Principe actif) |
|
II
|
5.5 G | Substance | Wirkstoff (Principe actif) |
|
I
|
- | Substance | WIZUS |
|
II
|
5.0 G | Substance | Wirkstoff (Principe actif) |
|
acidum hydrochloridum
|
- | Substance | HNIDK |
|
II
|
1.4 G | Substance | Wirkstoff (Principe actif) |
|
I
|
- | Substance | HNIDK |
|
II
|
2.3 G | Substance | Wirkstoff (Principe actif) |
|
II
|
3.4 G | Substance | Wirkstoff (Principe actif) |
|
II
|
3.0 G | Substance | Wirkstoff (Principe actif) |
|
II
|
- | Substance | WIZUS |
|
II
|
2.0 G | Substance | Wirkstoff (Principe actif) |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
II
|
2.3 G | Substance | Wirkstoff (Principe actif) |
|
II
|
5.1 G | Substance | Wirkstoff (Principe actif) |
|
II
|
3.0 G | Substance | Wirkstoff (Principe actif) |
|
II
|
460.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
2.0 G | Substance | Wirkstoff (Principe actif) |
|
II
|
910.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
180.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
2.8 G | Substance | Wirkstoff (Principe actif) |
|
II
|
260.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
- | Substance | WIZUS |
|
II
|
1.9 G | Substance | Wirkstoff (Principe actif) |
|
II
|
550.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
- | Substance | WIZUS |
|
II
|
2.0 G | Substance | Wirkstoff (Principe actif) |
|
II
|
1.6 G | Substance | Wirkstoff (Principe actif) |
|
II
|
- | Substance | WIZUS |
|
II
|
6.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
- | Substance | WIZUS |
|
acidum aceticum glaciale
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
III
|
12.2 G | Substance | Wirkstoff (Principe actif) |
|
III
|
12.2 G | Substance | Wirkstoff (Principe actif) |
|
III
|
10.2 G | Substance | Wirkstoff (Principe actif) |
|
III
|
6.1 G | Substance | Wirkstoff (Principe actif) |
|
III
|
- | Substance | Wirkstoff (Principe actif) |
|
III
|
- | Substance | HNIDK |
|
III
|
- | Substance | HNIDK |
|
III
|
- | Substance | HNIDK |
|
III
|
- | Substance | HNIDK |
|
123C
|
71.0 GL | Substance | Wirkstoff (Principe actif) |
|
123C
|
32.0 GL | Substance | Wirkstoff (Principe actif) |
|
123C
|
5.1 GL | Substance | Wirkstoff (Principe actif) |
|
123C
|
28.0 GL | Substance | Wirkstoff (Principe actif) |
|
123C
|
25.0 MMOLL | Substance | Wirkstoff (Principe actif) |
|
123C
|
19.0 MMOLL | Substance | Wirkstoff (Principe actif) |
|
123C
|
3.2 MMOLL | Substance | Wirkstoff (Principe actif) |
|
123C
|
1.6 MMOLL | Substance | Wirkstoff (Principe actif) |
|
123C
|
8.2 MMOLL | Substance | Wirkstoff (Principe actif) |
|
123C
|
0.02 MMOLL | Substance | Wirkstoff (Principe actif) |
|
123C
|
3.2 MMOLL | Substance | Wirkstoff (Principe actif) |
|
123C
|
22.0 MMOLL | Substance | Wirkstoff (Principe actif) |
|
123C
|
66.0 MMOLL | Substance | Wirkstoff (Principe actif) |
Authorization holder
Fresenius Kabi (Schweiz) AG
6010 Kriens
Authorization information
- Swissmedic authorization number
- 62448
- Drug name
- SmofKabiven peripher, Infusionsemulsion
- Galenic form
- EMUP
- ATC Code
- B05BA10
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 23/05/2013
- Authorization expiration date
- 31/12/9999
- IT number
- 07.01.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SMOFKABIVEN peripher 1448ml 1000 kcal sach 4 pce
- Description (DE)
- SMOFKABIVEN peripher 1448ml 1000 kcal Btl 4 Stk
- Narcotic (BTM)
- No